$599

EASD 2026 Key Press Releases (September 30 Part 2)

On the third day of EASD 2026, four key news items were observed in the afternoon from Lilly, AbbVie, Kailera Therapeutics, and Insilico Medicine. Below, FENIX provides context and analysis for the announcements.

This content is for Read Less members only.
Already a member? Log in here